Ser Educacional (SEER3) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
19 May, 2026Executive summary
Achieved strong double-digit growth in adjusted EBITDA and net operating cash generation, with adjusted EBITDA up 18.3% to R$122.5 million and net operating cash up 206.4% year-over-year, enabling a 9.3% reduction in net debt and resumption of dividend payments after three years.
Adjusted net income surged 101.3% to R$36.3 million in 4Q24, with margin expansion and improved leverage.
Operational optimization since 2022 has driven sustainable results, including margin expansion, improved cash flow, and reduced financial leverage for the eighth consecutive quarter.
Significant expansion in student base, especially in hybrid and health-related courses, with hybrid undergraduate intake up 16.7% and digital undergraduate intake up 9.2% year-over-year.
Dividend of R$19.6 million (R$0.15 per share) approved for May 2025, pending shareholder approval.
Financial highlights
Net revenue rose 8.7% year-over-year to R$523.8 million in 4Q24; full-year revenue up 8.2%.
Adjusted EBITDA increased 18.3% to R$122.5 million in 4Q24; margin expanded 1.9 p.p. to 23.4%.
Adjusted net income surged 101.3% to R$36.3 million in 4Q24; adjusted net margin up to 6.9%.
Net operating cash generation jumped 206.4% to R$50.1 million in 4Q24.
Net debt reduced by 9.3% to R$718.5 million; net debt/adjusted EBITDA improved from 2.17x to 1.64x.
Outlook and guidance
Entering 2025 with a larger number of medical student places, expected to be a key driver of future results.
Strategic focus on expanding medical schools and health-related courses, with disciplined expansion in high-demand areas and participation in Mais Médicos.
Continued focus on operational efficiency, cash generation, and further debt reduction, with plans for greater dividend distribution from 2026.
Ongoing operational optimization and portfolio reshaping to drive future growth and margin expansion.
New cycle of growth anticipated, supported by increased medical seats and new unit openings.
Latest events from Ser Educacional
- Net income surged 74% with strong on-campus growth, higher margins, and reduced net debt.SEER3
Q1 202619 May 2026 - Revenue and EBITDA surged in 3Q24, driven by health course growth and margin expansion.SEER3
Q3 202419 May 2026 - Adjusted net income rose 8.5% to R$46.2M, with margin and cash flow gains from hybrid and health courses.SEER3
Q2 202419 May 2026 - Record EBITDA and net income driven by hybrid and medical growth, efficiency, and deleveraging.SEER3
Q1 202519 May 2026 - Net income rose 66.4% and adjusted EBITDA increased 25% on strong hybrid and medical growth.SEER3
Q2 202519 May 2026 - Adjusted net income surged 112% and net debt fell 30%, led by hybrid and medical school growth.SEER3
Q4 202515 May 2026 - Adjusted net income up 24.5% and net debt down 21.9% on Hybrid Learning and margin gains.SEER3
Q3 202517 Nov 2025